TY - JOUR
T1 - Erratum
T2 - The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids (Cell Stem Cell (2019) 24(4) (621–636.e16), (S1934590919300724), (10.1016/j.stem.2019.02.020))
AU - Seneviratne, Ayesh K.
AU - Xu, Mingjing
AU - Aristizabal Henao, Juan J.
AU - Fajardo, Val A.
AU - Hao, Zhenyue
AU - Voisin, Veronique
AU - Xu, G. Wei
AU - Hurren, Rose
AU - Kim, S.
AU - MacLean, Neil
AU - Wang, Xiaoming
AU - Gronda, Marcela
AU - Jeyaraju, Danny
AU - Jitkova, Yulia
AU - Ketela, Troy
AU - Mullokandov, Michael
AU - Sharon, David
AU - Thomas, Geethu
AU - Chouinard-Watkins, Raphaël
AU - Hawley, James R.
AU - Schafer, Caitlin
AU - Yau, Helen Loo
AU - Khuchua, Zaza
AU - Aman, Ahmed
AU - Al-awar, Rima
AU - Gross, Atan
AU - Claypool, Steven M.
AU - Bazinet, Richard P.
AU - Lupien, Mathieu
AU - Chan, Steven
AU - De Carvalho, Daniel D.
AU - Minden, Mark D.
AU - Bader, Gary D.
AU - Stark, Ken D.
AU - LeBlanc, Paul
AU - Schimmer, Aaron D.
N1 - Publisher Copyright:
© 2019
PY - 2019/6/6
Y1 - 2019/6/6
N2 - (Cell Stem Cell 24, 621–636.e1–e16; April 4, 2019) We mistakenly approved an erroneous version of the title of our original manuscript, “The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.” It has now been corrected to, “The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids,” both here and in the version of our manuscript online. We apologize for the initial lack of clarity. Additionally, we have also corrected the name of one of our co-authors, which was originally listed as “Richard Bazinet” and now appears both here and online as “Richard P. Bazinet.” We apologize for any confusion.
AB - (Cell Stem Cell 24, 621–636.e1–e16; April 4, 2019) We mistakenly approved an erroneous version of the title of our original manuscript, “The Mitochondrial Transacylase, Tafazzin, Regulates for AML Stemness by Modulating Intracellular Levels of Phospholipids.” It has now been corrected to, “The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids,” both here and in the version of our manuscript online. We apologize for the initial lack of clarity. Additionally, we have also corrected the name of one of our co-authors, which was originally listed as “Richard Bazinet” and now appears both here and online as “Richard P. Bazinet.” We apologize for any confusion.
UR - http://www.scopus.com/inward/record.url?scp=85064882168&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064882168&partnerID=8YFLogxK
U2 - 10.1016/j.stem.2019.04.020
DO - 10.1016/j.stem.2019.04.020
M3 - Comment/debate
C2 - 31173706
AN - SCOPUS:85064882168
SN - 1934-5909
VL - 24
SP - 1007
JO - Cell stem cell
JF - Cell stem cell
IS - 6
ER -